These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9750383)

  • 1. [Squamous cell carcinoma markers in neoplasms of the uterine cervix].
    Freitag P; Fait T; Bendová M; Kostírová M; Zivný J
    Ceska Gynekol; 1998 Jun; 63(3):211-3. PubMed ID: 9750383
    [No Abstract]   [Full Text] [Related]  

  • 2. [Serum tumor markers SCC, TATI and TPS: value in follow-up of females with cervix cancer].
    Joura E; Gitsch G; Kainz C; Fröhlich B; Biegelmayr C; Kölbl H
    Gynakol Geburtshilfliche Rundsch; 1992; 32 Suppl 1():115. PubMed ID: 1286308
    [No Abstract]   [Full Text] [Related]  

  • 3. [Behavior of SCC marker level in cervix erosion, cervix dysplasia and cervical pre-invasive carcinoma].
    Uzar A; Rzepka-Górska I; Kosmowska B
    Ginekol Pol; 1992 Jan; 63(1):10-4. PubMed ID: 1304503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic value of heat shock protein 90
    Han S; Cheng Z; Zhao X; Huang Y
    J Int Med Res; 2019 Nov; 47(11):5518-5525. PubMed ID: 31426690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical value of squamous cell carcinoma antigen in cancer of the uterine cervix.
    de Bruijn HW; Duk JM; van der Zee AG; Pras E; Willemse PH; Boonstra H; Hollema H; Mourits MJ; de Vries EG; Aalders JG
    Tumour Biol; 1998; 19(6):505-16. PubMed ID: 9817980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus DNA in plasma of patients with HPV16 DNA-positive uterine cervical cancer.
    Shimada T; Yamaguchi N; Nishida N; Yamasaki K; Miura K; Katamine S; Masuzaki H
    Jpn J Clin Oncol; 2010 May; 40(5):420-4. PubMed ID: 20133337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Detection of recurrent cervix cancer with serum SCC measurement?].
    Bittl A; Böhm M; Kastner P; Di Paolo M; Jäger W
    Gynakol Geburtshilfliche Rundsch; 1993; 33 Suppl 1():228. PubMed ID: 8118284
    [No Abstract]   [Full Text] [Related]  

  • 8. Plasma levels of M-CSF and VEGF in laboratory diagnostics and differentiation of selected histological types of cervical cancers.
    Sidorkiewicz I; Zbucka-Krętowska M; Zaręba K; Lubowicka E; Zajkowska M; Szmitkowski M; Gacuta E; Ławicki S
    BMC Cancer; 2019 Apr; 19(1):398. PubMed ID: 31035945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experiences with SCC antigen, a new tumor marker for cervical carcinoma.
    Meier W; Eiermann W; Stieber P; Schneider A; Fateh-Moghadam A; Hepp H
    Eur J Cancer Clin Oncol; 1989 Nov; 25(11):1555-9. PubMed ID: 2591447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of squamous cell carcinoma antigen in cancer of the human uterine cervix. Comparison with CEA and CA-125.
    Verlooy H; Devos P; Janssens J; Mortelmans L; Gerits M; Bonte J; De Roo M
    Gynecol Obstet Invest; 1991; 32(1):55-8. PubMed ID: 1765320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum tumour markers in carcinoma of the uterine cervix and outcome following radiotherapy.
    Sproston AR; Roberts SA; Davidson SE; Hunter RD; West CM
    Br J Cancer; 1995 Dec; 72(6):1536-40. PubMed ID: 8519673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum CYFRA 21-1 assay in squamous cell carcinoma of the cervix.
    Ferdeghini M; Gadducci A; Annicchiarico C; Prontera C; Malagnino G; Castellani C; Facchini V; Bianchi R
    Anticancer Res; 1993; 13(5C):1841-4. PubMed ID: 7505543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of cervical cancer radioresponse by serum squamous cell carcinoma antigen and magnetic resonance imaging.
    Ohara K; Tanaka Y; Tsunoda H; Nishida M; Sugahara S; Itai Y
    Obstet Gynecol; 2002 Oct; 100(4):781-7. PubMed ID: 12383549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Squamous cell carcinoma antigen in cervical cancer.
    Borras G; Molina R; Xercavins J; Ballesta A; Iglesias X
    Eur J Gynaecol Oncol; 1992; 13(5):414-8. PubMed ID: 1486921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-specific correlation of tumor M2 pyruvate kinase in pre-invasive, invasive and recurrent cervical cancer.
    Landt S; Jeschke S; Koeninger A; Thomas A; Heusner T; Korlach S; Ulm K; Schmidt P; Blohmer JU; Lichtenegger W; Sehouli J; Kuemmel S
    Anticancer Res; 2010 Feb; 30(2):375-81. PubMed ID: 20332442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of tumor markers SCC-Ag, CEA, and TPA in patients with cervical precancerous lesions.
    Farzaneh F; Shahghassempour S; Noshine B; Arab M; Yaseri M; Rafizadeh M; Alizadeh K
    Asian Pac J Cancer Prev; 2014; 15(9):3911-4. PubMed ID: 24935573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of serum levels of different cytokeratins in patients with uterine malignancies.
    Ferdeghini M; Gadducci A; Prontera C; Castellani C; Annicchiarico C; Gagetti O; Facchini V; Bianchi R
    Anticancer Res; 1994; 14(3B):1393-7. PubMed ID: 7520682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Tumor marker squamous cell carcinoma antigen].
    Lavie O; Neuman M; Zuckerman B; Hornreich G; Beller U
    Harefuah; 1998 Sep; 135(5-6):222-5. PubMed ID: 9885641
    [No Abstract]   [Full Text] [Related]  

  • 19. [Experiences with the squamous cell carcinoma antigen, a new tumor marker for cancer of the uterine cervix].
    Meier W; Eiermann W; Stieber P; Fateh-Moghadam A; Hepp H
    Geburtshilfe Frauenheilkd; 1989 Jul; 49(7):625-9. PubMed ID: 2777050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of post-radiation serum squamous cell carcinoma antigen and primary tumor regression for cervical squamous cell carcinoma.
    Wan Q; Yan W; Liu Y; Lin Y; Lu Z
    Cancer Biomark; 2020; 29(3):327-335. PubMed ID: 32716344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.